Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2019
Jul. 31, 2019
Document and Entity Information    
Entity Registrant Name BioXcel Therapeutics, Inc.  
Entity Central Index Key 0001720893  
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   15,731,395
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Entity Shell Company false  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true